You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Genentech, Inc. Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Genentech, Inc.
Patents:30
Tradenames:27
Ingredients:25
BLAs:27

Biologic Drugs for Genentech, Inc.

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Genentech, Inc. NUTROPIN somatropin For Injection 020168 1993-11-17 ⤷  Sign Up
Genentech, Inc. NUTROPIN AQ somatropin Injection 020522 1995-12-29 ⤷  Sign Up
Genentech, Inc. ACTIVASE alteplase For Injection 103172 1987-11-13 ⤷  Sign Up
Genentech, Inc. PULMOZYME dornase alfa Solution 103532 1993-12-30 ⤷  Sign Up
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Sign Up
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 1998-09-25 ⤷  Sign Up
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.